Document Detail


High glucose upregulates upstream stimulatory factor 2 in human renal proximal tubular cells through angiotensin II-dependent activation of CREB.
MedLine Citation:
PMID:  20814220     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/AIMS: We have previously demonstrated that a transcription factor, upstream stimulatory factor 2 (USF2), regulates glucose-induced thrombospondin 1 expression and transforming growth factor-β activity in mesangial cells, and plays an important role in diabetic glomerulopathy. In this study, we determined whether USF2 expression in renal proximal tubular cells is regulated by glucose and contributes to diabetic tubulointerstitial fibrosis.
METHODS: Human renal proximal tubular cells (HK-2 cells) were treated with normal- or high-glucose medium for 24 h. After treatment, real-time PCR or immunoblotting was used to determine the expression of USF2 and other components of the renin-angiotensin system in HK-2 cells.
RESULTS: High glucose upregulated USF2 expression and increased extracellular matrix accumulation in HK-2 cells; both were inhibited by siRNA-mediated USF2 knockdown. In addition, high glucose stimulated angiotensinogen and renin expression, increased renin activity, and resulted in increased angiotensin II formation. Treatment of HK-2 cells with an angiotensin II receptor 1 (AT1) blocker--losartan--prevented high-glucose-induced USF2 expression and high-glucose-enhanced phosphorylation of CREB (cAMP response element-binding protein).
CONCLUSION: Our data established that high glucose stimulated USF2 expression in HK-2 cells, at least in part, through angiotensin II-AT1-dependent activation of CREB, which can contribute to diabetic tubulointerstitial fibrosis.
Authors:
Nishant P Visavadiya; Yanzhang Li; Shuxia Wang
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-09-01
Journal Detail:
Title:  Nephron. Experimental nephrology     Volume:  117     ISSN:  1660-2129     ISO Abbreviation:  Nephron Exp. Nephrol.     Publication Date:  2011  
Date Detail:
Created Date:  2011-03-01     Completed Date:  2011-06-17     Revised Date:  2012-01-02    
Medline Journal Info:
Nlm Unique ID:  101159770     Medline TA:  Nephron Exp Nephrol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  e62-70     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 S. Karger AG, Basel.
Affiliation:
Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, KY 40536-0200, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II / metabolism
Cell Line
Cyclic AMP Response Element-Binding Protein / metabolism*
Diabetic Nephropathies / physiopathology
Glucose / administration & dosage*,  pharmacology
Humans
Kidney Tubules, Proximal / cytology,  metabolism*,  physiopathology
Losartan / pharmacology
Peptidyl-Dipeptidase A / metabolism
Renin / biosynthesis
Renin-Angiotensin System
Up-Regulation
Upstream Stimulatory Factors / metabolism*
Grant Support
ID/Acronym/Agency:
R01 DK081555/DK/NIDDK NIH HHS; R01 DK081555-02/DK/NIDDK NIH HHS; R01 DK081555-03/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Cyclic AMP Response Element-Binding Protein; 0/USF2 protein, human; 0/Upstream Stimulatory Factors; 11128-99-7/Angiotensin II; 114798-26-4/Losartan; 50-99-7/Glucose; EC 3.4.15.1/Peptidyl-Dipeptidase A; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Suppression of Par-4 protects human renal proximal tubule cells from apoptosis induced by oxidative ...
Next Document:  Transient Receptor Potential Melastatin 6 Knockout Mice Are Lethal whereas Heterozygous Deletion Res...